Bone union for Mesoblast

Mesoblast's [ASX: MSB] adult stem cells have been shown to repair non-healing bones in long-term sufferers.

The company, in conjunction with the Royal Melbourne Hospital, today released results of a clinical trial involving patients which had suffered non-united fractures for up to 41 months prior to being implanted with Mesoblast's stem cells.

Of the 11 patients in the trial, nine achieved bone union within an average time of four months.

Eight of these patients have been able to bear weight on the affected limbs and resume daily activities. The ninth had suffered fractures of the tibia and the femur, and only achieved bone union in the tibia.

The two remaining patients had suffered complex trauma from car accidents involving multiple bones, and required repeat orthopaedic surgery after the trial.